← All Sponsors
SPONSOR

Theolytics Limited

Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 1, Phase 2
Conditions studied: Ovarian Cancer
NCT07211659 Phase 1
Recruiting

Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients

Ovarian Cancer
United States View Trial →
NCT06618235 Phase 1, Phase 2
Recruiting

Trial of THEO-260 in Ovarian Cancer Patients

Ovarian Cancer
United Kingdom View Trial →